Red blood cell distribution width is associated with sarcopenia risk in early-stage non-small cell lung cancer

被引:1
作者
Jia, Qing-chun [1 ]
Qin, Ling [2 ]
Niu, Ye [1 ]
Liu, Le [1 ]
Liu, Ping-ping [1 ]
Miao, Shi-di [3 ]
Cui, Ming-ming [1 ]
Wang, Rui-tao [1 ]
机构
[1] Harbin Med Univ, Harbin Med Univ Canc Hosp, Dept Internal Med, 150 Haping ST, Harbin 150081, Heilongjiang, Peoples R China
[2] Harbin Med Univ, Harbin Med Univ Canc Hosp, Dept Pathol, Harbin 150081, Heilongjiang, Peoples R China
[3] Harbin Univ Sci & Technol, Sch Comp Sci & Technol, Harbin 150080, Heilongjiang, Peoples R China
关键词
Red blood cell distribution; Sarcopenia; Non-small cell lung cancer; Computed tomography; MARKERS; INFLAMMATION; MUSCLE;
D O I
10.1186/s12885-024-11864-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Sarcopenia has received increasing attention in non-small cell lung cancer (NSCLC). Red blood cell distribution width (RDW) is a significant component of the complete blood count and indicates the heterogeneity of erythrocyte volume. Little information is known about RDW in relation to sarcopenia in early-stage (IA-IIIA) NSCLC. The purpose of the present study was to investigate the association between RDW and sarcopenia risk in early-stage NSCLC patients.Methods This study included 378 patients with pathologically confirmed stage IA-IIIA NSCLC. Sarcopenia was defined by measuring the skeletal muscle index (SMI) at the eleventh thoracic vertebra level. The maximum Youden index on the receiver operating characteristic (ROC) curve was used to estimate the cutoff value for RDW to predict sarcopenia. Logistic regression analyses were carried out to assess the independent risk factors for sarcopenia in NSCLC.Results The ROC curve indicated that the best cutoff point for RDW to predict sarcopenia was 12.9 (sensitivity of 43.80% and specificity of 76.76%, respectively). Moreover, there were significant differences in hemoglobin (p < 0.001), comorbidities (p = 0.001), histological type (p = 0.002), and cancer stage (p = 0.032) between the high RDW and low RDW groups. Logistic regression analyses revealed that high RDW is an independent risk factor for sarcopenia in early-stage NSCLC.Conclusion RDW is associated with sarcopenia risk in early-stage NSCLC.
引用
收藏
页数:8
相关论文
共 50 条
  • [11] Progress in the Treatment and Outcomes for Early-Stage Non-Small Cell Lung Cancer
    Shin, Jacob Y.
    Yoon, Ja Kyoung
    Marwaha, Gaurav
    LUNG, 2018, 196 (03) : 351 - 358
  • [12] Immunotherapy for early-stage non-small cell lung cancer: A system review
    Gao, Jingyi
    Zhang, Chao
    Wei, Zhigang
    Ye, Xin
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (04) : 849 - 865
  • [13] Waiting times in early-stage non-small cell lung cancer (NSCLC)
    Saint-Jacques, Nathalie
    Rayson, Daniel
    Al-Fayea, Turki
    Virik, Kiran
    Morzycki, Wojciech
    Younis, Tallal
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (08) : 865 - 870
  • [14] Features of fatigue in patients with early-stage non-small cell lung cancer
    Huang, Xianping
    Zhou, Weihe
    Zhang, Yuefeng
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2015, 20 (03): : 268 - 272
  • [15] Nonintubated thoracoscopic surgery for early-stage non-small cell lung cancer
    Hung, Wan-Ting
    Cheng, Ya-Jung
    Chen, Jin-Shing
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2020, 68 (07) : 733 - 739
  • [16] Management of Early-Stage Resected Non-Small Cell Lung Cancer: Consensus Statement of the Lung cancer Consortium
    Allehebi, Ahmed
    Al Kattan, Khaled
    Al Rujaib, Mashael
    Al Dayel, Fouad
    Black, Edward
    Mahrous, Mervat
    AlNassar, Muath
    Al Hussaini, Hamed
    Al Twairgi, Abdullah
    Abdelhafeiz, Nafisa
    Al Omair, Ameen
    Al Shehri, Salem
    Al-Shamsi, Humaid O.
    Jazieh, Abdul Rahman
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2022, 31
  • [17] Progress in the Management of Early-Stage Non-Small Cell Lung Cancer in 2017
    Donington, Jessica S.
    Kim, Young Tae
    Tong, Betty
    Moreira, Andre L.
    Bessich, Jamie
    Weiss, Kathleen D.
    Colson, Yolonda L.
    Wigle, Dennis
    Osarogiagbon, Raymond U.
    Zweig, Jeffrey
    Wakelee, Heather
    Blasberg, Justin
    Daly, Megan
    Backhus, Leah
    Van Schil, Paul
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (06) : 767 - 778
  • [18] Segmentectomy for patients with early-stage pure-solid non-small cell lung cancer
    Kamigaichi, Atsushi
    Hamada, Akira
    Tsutani, Yasuhiro
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [19] Prognostic role of TPL2 in early-stage non-small cell lung cancer
    Boldrini, Laura
    Giordano, Mirella
    Servadio, Adele
    Niccoli, Cristina
    Bertoglio, Pietro
    Lucchi, Marco
    Melfi, Franca
    Mussi, Alfredo
    Fontanini, Gabriella
    MOLECULAR MEDICINE REPORTS, 2017, 15 (06) : 3451 - 3458
  • [20] Adjuvant Chemotherapy in Elderly Patients with Early-stage Non-small Cell Lung Cancer
    Kefeli, Umut
    Kaymaz, Samet
    Aydin, Dincer
    Isik, Deniz
    Cabuk, Devrim
    Sonkaya, Alper
    Acikgoz, Ozgur
    Isik, Ulas
    Ozden, Ercan
    Uygun, Kazim
    BEZMIALEM SCIENCE, 2019, 7 (04): : 265 - 270